{
  "id": 26078,
  "title": "UCB's stock slides despite Bimzelx revenue beating forecasts",
  "url": "https://urgent.news/2026/07/30/ucbs-stock-slides-despite-bimzelx-revenue-beating-forecasts",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-07-30T15:24:12.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ucb-stock-slides-despite-bimzelx-revenue-beating-forecasts/"
  },
  "original_language": "en",
  "account": null,
  "summary": "UCB's shares dropped Thursday on investor concern that the Belgian pharma could be overpromising on its full-year forecast, even as sales of its lead drug topped analysts' expectations. The company reported Bimzelx, which is used ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}